The role of hemolysate in the facilitation of oxyhemoglobin-induced contraction in rabbit basilar arteries.
The importance of factors within hemolysate in modulating oxyhemoglobin (oxyHb)-induced contraction was examined in an in vitro model of rabbit basilar arteries. When the basilar arteries were exposed to purified oxyHb alone, the contractile response observed was significantly weaker than that seen in arteries exposed to hemolysate containing an equal concentration of oxyHb. In order to delineate the nature of the factors within hemolysate that facilitate contraction, hemolysate was fractionated, and various components were tested individually for their ability to elicit this effect. A low-molecular-weight fraction of hemolysate, ranging from 0.5 to 2.0 kD, elicited only a mild contraction. However, when this fraction was combined with purified oxyHb, the contractile response was comparable in magnitude to that of unfractionated hemolysate. These studies confirm that purified oxyHb is capable of inducing contraction in vitro. The data also demonstrate that oxyHb elicits a significantly weaker contraction than does hemolysate. In addition, the results suggest that low-molecular-weight components in hemolysate (in the 0.5- to 2.0-kD range), while incapable of inducing a potent contraction alone, may act in concert with oxyHb to elicit the vasoconstriction seen following subarachnoid hemorrhage.
Department of Neurological Surgery, University of Virginia, Charlottesville.
T
T
Aoki
K
K
Takenaka
S
S
Suzuki
N F
NF
Kassell
O
O
Sagher
K S
KS
Lee
D000109:Acetylcholine / Q000008:administration & dosage / Q000494:pharmacology; D000818:Animals; D001488:Basilar Artery / Q000187:drug effects / Q000502:physiology*; D004305:Dose-Response Relationship, Drug; D004730:Endothelium, Vascular / Q000187:drug effects; D006461:Hemolysis / Q000502:physiology*; D008297:Male; D008970:Molecular Weight; D010108:Oxyhemoglobins / Q000008:administration & dosage / Q000494:pharmacology / Q000502:physiology*; D011189:Potassium Chloride / Q000008:administration & dosage / Q000494:pharmacology; D011817:Rabbits; D012701:Serotonin / Q000008:administration & dosage / Q000494:pharmacology; D014661:Vasoconstriction / Q000187:drug effects / Q000502:physiology*; D014664:Vasodilation / Q000187:drug effects
D010108:Oxyhemoglobins; D012701:Serotonin; D011189:Potassium Chloride; D000109:Acetylcholine